Discovery Capital’s Quarterly Healthcare Sector Position Changes: WPI, SLXP, MNTA, YMI

Wall St. Watchdog reveals information regarding Discovery Capital Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 7 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $243.354 million.

  • Watson Pharmaceuticals Inc. (NYSE:WPI): On 06/30/2011, Discovery Capital Management reported holding 986,518 shares with a market value of $67,803,385. This comprised 2.26% of the total portfolio. On 09/30/2011, Discovery Capital Management reported holding 1,256,018 shares with a market value of $85,723,229. This comprised 2.95% of the total portfolio. The net change in shares for this position over the two quarters is 269,500. About Company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products.
  • Salix Pharmaceuticals Ltd. (NASDAQ:SLXP): On 06/30/2011, Discovery Capital Management reported holding 1,418,150 shares with a market value of $56,484,917. This comprised 1.89% of the total portfolio. On 09/30/2011, Discovery Capital Management reported holding 1,561,550 shares with a market value of $46,221,881. This comprised 1.59% of the total portfolio. The net change in shares for this position over the two quarters is 143,400. About Company: Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Discovery Capital Management reported holding 286,800 shares with a market value of $14,793,145. This comprised 0.49% of the total portfolio. On 09/30/2011, Discovery Capital Management reported holding 759,900 shares with a market value of $35,046,587. This comprised 1.2% of the total portfolio. The net change in shares for this position over the two quarters is 473,100. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Momenta Pharmaceuticals Inc. (NASDAQ:MNTA): On 06/30/2011, Discovery Capital Management reported holding 1,876,711 shares with a market value of $36,520,794. This comprised 1.22% of the total portfolio. On 09/30/2011, Discovery Capital Management reported holding 2,725,911 shares with a market value of $31,347,977. This comprised 1.08% of the total portfolio. The net change in shares for this position over the two quarters is 849,200. About Company: Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Discovery Capital Management reported holding 0 shares. On 09/30/2011, Discovery Capital Management reported holding 411,100 shares with a market value of $20,818,104. This comprised 0.72% of the total portfolio. The net change in shares for this position over the two quarters is 411,100. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Life Technologies Corporation (NASDAQ:LIFE): On 06/30/2011, Discovery Capital Management reported holding 0 shares. On 09/30/2011, Discovery Capital Management reported holding 505,200 shares with a market value of $19,414,836. This comprised 0.67% of the total portfolio. The net change in shares for this position over the two quarters is 505,200. About Company: Life Technologies Corporation develops biotechnology tools used by researchers. The Company offers a broad range of products and services, including systems, instruments, reagents, and custom services. Life’s portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry sample preparation, and cell culture.
  • Ym Biosciences Inc. (AMEX:YMI): On 06/30/2011, Discovery Capital Management reported holding 2,327,650 shares with a market value of $6,540,696. This comprised 0.22% of the total portfolio. On 09/30/2011, Discovery Capital Management reported holding 2,570,450 shares with a market value of $4,781,037. This comprised 0.16% of the total portfolio. The net change in shares for this position over the two quarters is 242,800. About Company: YM Biosciences Inc. is developing cancer drugs based on technologies licensed primarily from international academic centers. The Company is currently developing a small molecule chemopotentiator for metastatic breast cancer, an EGFr humanized monoclonal antibody, and a GnRH cancer vaccine. YM is also supporting the preclinical development of additional cancer products.

(Note: Data regarding Discovery Capital Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet